XML 53 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes
12 Months Ended
Dec. 31, 2019
Income Taxes [Abstract]  
Income Taxes
11.
Income Taxes

Consolidated income before provision for income taxes consists of the following for the years ended December 31, 2019, 2018 and 2017 (U.S. dollars in thousands):


 
2019
   
2018
   
2017
 
U.S.
 
$
24,211
   
$
(67,087
)
 
$
1,135
 
Foreign
   
230,961
     
286,753
     
264,432
 
Total
 
$
255,172
   
$
219,666
   
$
265,567
 

The provision for current and deferred taxes for the years ended December 31, 2019, 2018 and 2017 consists of the following (U.S. dollars in thousands):


 
2019
   
2018
   
2017
 
Current
                 
Federal
 
$
   
$
   
$
(14,358
)
State
   
2,213
     
652
     
1,814
 
Foreign
   
79,694
     
116,303
     
104,688
 
     
81,907
     
116,955
     
92,144
 
Deferred
                       
Federal
   
(8,878
)
   
(17,836
)
   
45,593
 
State
   
(473
)
   
(1,974
)
   
(2,273
)
Foreign
   
9,063
     
634
     
666
 
     
(288
)
   
(19,176
)
   
43,986
 
Provision for income taxes
 
$
81,619
   
$
97,779
   
$
136,130
 

The principal components of deferred taxes are as follows (U.S. dollars in thousands):


 
Year Ended December 31,
 
   
2019
   
2018
 
Deferred tax assets:
           
Inventory differences
 
$
5,040
   
$
4,257
 
Foreign tax credit and other foreign benefits
   
69,820
     
62,521
 
Stock-based compensation
   
7,441
     
7,893
 
Accrued expenses not deductible until paid
   
35,374
     
40,509
 
Foreign currency exchange
   
163
     
1,023
 
Net operating losses
   
6,341
     
4,522
 
Capitalized research and development
   
18,716
     
11,988
 
Interest expense limitation – 163(j)
   
     
847
 
R&D credit carryforward
   
881
     
807
 
Other
   
37
     
339
 
Gross deferred tax assets
   
143,813
     
134,706
 
Deferred tax liabilities:
               
Foreign currency exchange
   
721
     
124
 
Foreign withholding taxes
   
20,986
     
21,524
 
Intangibles step-up
   
4,958
     
5,763
 
Overhead allocation to inventory
   
3,611
     
2,857
 
Amortization of intangibles
   
15,393
     
15,812
 
Other
   
1,063
     
833
 
Gross deferred tax liabilities
   
46,732
     
46,913
 
Valuation allowance
   
(77,042
)
   
(68,697
)
Deferred taxes, net
 
$
20,039
   
$
19,096
 

At December 31, 2019, the Company had foreign operating loss carryforwards of $18.2 million for tax purposes, which will be available to offset future taxable income. If not used, $6.3 million of carryforwards will expire between 2020 and 2029, while $11.9 million do not expire. A valuation allowance has been placed on foreign operating loss carryforwards of $18.2 million, tax effected the valuation on the net operating loss is $6.3 million. In addition, a valuation allowance has been recorded on the foreign tax credit carryforward, and the R&D credit carryforward of $70.7 million which will expire between 2026 and 2029.

The Company uses the tax law ordering approach when determining when excess tax benefits have been realized.

The valuation allowances have been recognized for the foreign tax credit, the foreign net operating loss carryforwards, and the R&D credit carryforward.  The valuation allowances were recognized for assets which it is more likely than not some portion or all of the deferred tax asset will not be realized. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary difference, projected future taxable income, tax planning strategies and recent financial operations. When the Company determines that there is sufficient positive evidence to utilize the foreign tax credits, the foreign net operating losses, or the R&D credit carryforward, the valuation will be released which would reduce the provision for income taxes.

The deferred tax asset valuation adjustments for the years ended December 31, 2019, 2018 and 2017 are as follows (U.S. dollars in thousands):


 
Year Ended December 31,
 
   
2019
   
2018
   
2017
 
Balance at the beginning of period
 
$
68,697
   
$
56,906
   
$
9,137
 
Additions charged to cost and expenses
   
10,913
(1) 
   
27,902
(4) 
   
53,983
(6) 
Decreases
   
(3,343
)(2)
   
(16,215
)(5)
   
(6,400
)(7)
Adjustments
   
775
(3) 
   
104
(3) 
   
186
(3) 
Balance at the end of the period
 
$
77,042
   
$
68,697
   
$
56,906
 

(1)
Increase in valuation is due primarily to $9.8 million that was recorded on the foreign tax credit carryforward. The additional amount is due to net operating losses in foreign markets.
(2)
The decrease was due primarily to the utilization of foreign tax credits, and expiration of foreign net operating losses.
(3)
Represents the net currency effects of translating valuation allowances at current rates of exchange.
(4)
Increase in valuation is due primarily to the $27.2 million that was recorded on the foreign tax credit carryforward. The additional amount is due to net operating losses in foreign markets
(5)
The decrease was due primarily to the utilization of foreign tax credits. Decrease is due primarily to the write-off of Brazil deferred tax assets, which had no impact to the income statement, as a valuation allowance had been previously recorded against the asset.
(6)
Increase in valuation allowance is due primarily to the $52.0 million that was recorded on the foreign tax credit carryforward. The additional amount is due to net operating losses in foreign markets.
(7)
Decrease is due primarily to the write-off of Brazil deferred tax assets, which had no impact to the income statement, as a valuation allowance had been previously recorded against the asset.

The components of deferred taxes, net on a jurisdiction basis are as follows (U.S. dollars in thousands):


 
Year Ended December 31,
 
   
2019
   
2018
 
Net noncurrent deferred tax assets
 
$
30,780
   
$
37,332
 
Net noncurrent deferred tax liabilities
   
10,741
     
18,236
 
Deferred taxes, net
 
$
20,039
   
$
19,096
 

The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in proposed assessments that may result in additional tax liabilities.


The actual tax rate for the years ended December 31, 2019, 2018 and 2017 compared to the statutory U.S. Federal tax rate is as follows:


 
Year Ended December 31,
 
   
2019
   
2018
   
2017
 
Income taxes at statutory rate
   
21.00
%
   
21.00
%
   
35.00
%
Indefinite reinvestment
   
     
(2.73
)%
   
2.75
%
Excess tax benefit from equity award
   
0.02
%
   
(1.41
)%
   
(2.38
)%
Non-U.S. income taxed at different rates
   
3.09
%
   
7.37
%
   
 
Foreign withholding taxes
   
4.10
%
   
7.68
%
   
 
Change in reserve for uncertain tax positions
   
1.07
%
   
3.68
%
   
 
Non-deductible expenses
   
     
     
0.17
%
Controlled foreign corporation losses
   
     
     
(0.13
)%
Valuation allowance recognized foreign tax credit & others
   
2.56
%
   
5.54
%
   
19.59
%
Write-off outside basis DTL
   
     
     
(2.89
)%
Revaluation of deferred taxes
   
     
1.61
%
   
(1.28
)%
Foreign-Derived Intangible Income (FDII)
   
(0.70
)%
   
     
 
Other
   
0.85
%
   
1.77
%
   
0.43
%
     
31.99
%
   
44.51
%
   
51.26
%

The effective rate for 2018 was significantly impacted by the restructuring and impairment expenses incurred in Q4 of 2018, as well as additional valuation allowances related to foreign tax credits. The effective tax rate for 2017 was impacted largely due to the Tax Reform Act.

The cumulative amount of undistributed earnings of the Company’s non-U.S. Subsidiaries held for indefinite reinvestment is approximately $60.0 million, at December 31, 2019.  If this amount were repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million.